
TSE:L
This summary was created by AI, based on 10 opinions in the last 12 months.
Loblaw Companies Ltd is recognized as a dominant player in the Canadian grocery and pharmacy sector, benefiting from strong brand loyalty and private label offerings. Despite its robust performance, experts express concerns regarding its valuation, with some calling for caution due to the perception of shrinking growth potential and increased competition from retailers like Walmart and Costco. While some analysts view Loblaw as a defensive investment that could provide stability in uncertain economic times, others critique its recent price surges and suggest trimming positions. The company's acquisition of Shoppers Drug Mart is praised for unlocking profitability, though comparisons with ATD highlight some hesitancy among investors. Overall, while Loblaw has shown resilience amid food inflation, market sentiment varies, indicating mixed outlooks on its future performance.
Food retailing is defensive. Unlike Empire, Loblaw owns Shoppers which gives it an edge. Loblaw is expanding their health business, entering digital health with a new acquisition. The locations of both Loblaw and SDM are great and boast a 30% market share. People are becoming comfortable using online medical services, a trend that will continue across North America long term. The growth rate in their click-and-collect and grocery delivery may not be that strong, but will continue to rise. Trades at 14x forward earnings, reasonable. The dividend is a moderate 2%. Even if we enter high volatility, this sector and stock will be fine. (Analysts’ price target is $80.82)
(A Top Pick Jul 10/19, Up 6%) Relatively defensive with food and pharma. Nice defensive stock to own in this environment. Pantry loading with Covid, but they also have higher costs with protection equipment and higher labour costs. Leader in online grocery. The trading discount from Metro should narrow over time.
Are grocers safe? Yes, during this stay at home phase. Loblaw trades at 16x forward PE with a 7% growth rate. It's low beta at half the volatility of the TSX. Q2 will probably be good in terms of revenues. But he's concerned with their private label segment has required a lot of investment. Also, Loblaw is highly unionized and faces wage pressure. He prefers Metro a bit for its better valuation.